MedTrace Logo

Circulating Markers in Preterm Infants With Perinatal and Neonatal Inflammation

NCT03320785 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2022-03-23

No results posted yet for this study

Summary

Circulating markers to diagnose complications (sepsis, necrotizing enterocolitis) in preterm infants are often inaccurate, partly due to the lack of comprehensive studies with temporal evaluation from birth until a disease onset. The investigators plan to collect weekly blood samples of preterm infants from birth until 4 weeks of age to comprehensively characterize differential protein and epigenetic markers in infants with and without complications (sepsis, necrotizing enterocolitis, chorioamnionitis).

Conditions

  • Sepsis
  • Necrotizing Enterocolitis
  • Chorioamnionitis
  • Feeding Intolerance

Sponsors & Collaborators

  • Baoan Maternal And Child Health Care Hospital, Shenzhen, China

    collaborator UNKNOWN

  • Per Torp Sangild

    lead OTHER

Principal Investigators

  • Per T Sangild, PhD · Rigshospitalet, Denmark

Eligibility

Min Age
1 Day
Max Age
1 Day
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-09-01
Primary Completion
2019-10-01
Completion
2021-12-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03320785 on ClinicalTrials.gov